Patent: 6,239,144
✉ Email this page to a colleague
Summary for Patent: 6,239,144
Title: | Methods of treating bone loss |
Abstract: | The present invention provides methods of treating or preventing conditions associated with a lack of parathyroid hormone comprising administering to a mammal in need thereof an effective amount of a compound having activity as a tachykinin receptor antagonist. In a most preferred embodiment the present invention provides methods of increasing bone growth in a mammal which comprises administering to a mammal in need thereof an effective amount of a compound having activity as a tachykinin receptor antagonist. Another embodiment of this invention provides methods of treating hyperparathyroidism in a mammal comprising administering to a mammal in need thereof an effective amount of a compound having activity as a tachykinin receptor antagonist. |
Inventor(s): | Galvin; Rachelle J (Indianapolis, IN), Gitter; Bruce D (Carmel, IN) |
Assignee: | Eli Lilly and Company (Indianapolis, IN) |
Application Number: | 09/319,388 |
Patent Claims: | see list of patent claims |
Details for Patent 6,239,144
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Nps Pharmaceuticals, Inc. | NATPARA | parathyroid hormone | For Injection | 125511 | 01/23/2015 | ⤷ Try a Trial | 2017-04-03 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |